Purpose: To evaluate whether high-resolution optical coherence tomography (HR-OCT) can aid in differentiation of inflammatory versus noninflammatory causes of peripheral corneal thinning.
T he peripheral cornea is anatomically and physiologically distinct from the central cornea. Anatomically, the peripheral cornea is thicker than the central cornea, 1 whereas the central cornea has a higher density of keratocytes and nerves. 2 Physiologically, the peripheral cornea is near lymphatics, blood vessels, and inflammatory cells 3 and is thus more vulnerable to injury from autoimmune conditions. Slit-lamp biomicroscopy has been the mainstay in the examination of the peripheral cornea, and it is still the first step in the approach to peripheral corneal diseases. The presence of injected limbal vessels, stromal thinning, an overlying epithelial defect, corneal opacities, lipid deposition, and/or vascularization provides important diagnostic clues to the underlying etiology of the peripheral disease. Specifically, eye-care professionals use these signs to help differentiate inflammatory diseases such as peripheral ulcerative keratitis (PUK) and marginal keratitis from degenerative conditions like Terrien marginal degeneration (TMD). Some patients, however, present with peripheral corneal thinning without a clear etiology or diagnosis. In some of these cases, slit-lamp examination alone cannot definitely diagnose whether the thinning is inflammatory or degenerative in nature. For example, TMD, as originally described, was believed to be a noninflammatory degenerative condition. 4 Subsequently, various groups have reported corneal thinning in patients with conjunctival hyperemia, tearing, photophobia, and irritation, but without systemic abnormalities, and termed this entity "inflammatory TMD". 5, 6 Furthermore, systemic inflammatory diseases such as juvenile idiopathic arthritis, 7 rheumatoid arthritis, 8, 9 and vasculitis 10 have been associated with this variant of TMD. In these cases, it is difficult to determine the underlying disease process.
Anterior segment high-resolution optical coherence tomography (HR-OCT) provides excellent anatomic resolution of the anterior segment structures and as such has been found clinically useful for the examination, diagnosis, and management of various anterior segment conditions. 11 For example, HR-OCT has been used to diagnose and monitor ocular surface squamous neoplasia, 12, 13 help plan refractive and cornea surgeries, 14 and diagnose postsurgical complications.
Previous studies have demonstrated the ability of HR-OCT to detect morphologic changes in areas of thinning not apparent on clinical examination. For example, Hattori et al used HR-OCT to detect cavity formation in the stroma under the area of thinning in 2 patients with a clinical diagnosis of TMD, only one of which was apparent on clinical examination. 16 Others have proposed a novel staging system based on the curvature of the cornea as assessed by HR-OCT in patients with TMD. 17 In this study, our aim was to evaluate whether HR-OCT could help differentiate between inflammatory versus degenerative peripheral corneal thinning. We evaluated HR-OCT images of 5 patients with a clinical diagnosis of degenerative peripheral corneal thinning and compared them with HR-OCT images of 5 patients with peripheral corneal thinning whose etiology was believed to be inflammatory in nature.
METHODS
The peripheral cornea of 10 patients with peripheral corneal thinning was evaluated by Heidelberg Spectralis (Heidelberg Engineering, Heidelberg, Germany, OCT specifications: 40,000 A scans/second, axial resolution 3.9 mm, tranverse resolution 14 mm, scan depth 1.9 mm, average wavelength 870 nm). This was done after routine ophthalmic examination, which included visual acuity, intraocular pressure measurement, and slit-lamp examination. Retrospective chart review was performed to correlate HR-OCT images to clinical data, and the patient's privacy was protected during data collection and analysis. The Miami VA institutional review board approved the retrospective review of patient charts.
RESULTS
We identified 10 patients with peripheral corneal thinning noted on examination who underwent imaging with HR-OCT. Mean patient age was 60.3 years (SD 20.1, range 27-85 years).
Of the patients, 7 were male and 3 were female; 8 self-identified as white, 1 as black, and 1 as Hispanic (Table 1 ). Demographics and comorbidities were similar between the groups ( Table 2) . None of the patients had a history of trauma or ocular surgery.
Of the 10 patients, 5 had a history of indolent peripheral thinning, with no associated pain, redness, or photophobia. None of these patients had a history of systemic autoimmune disorders. All eyes were white and quiet, without evidence of conjunctival hyperemia or corneal epithelial defects over the areas of peripheral corneal thinning, and therefore fit the profile of classic TMD (Figs. 1A-C) . HR-OCT images of the "noninflammatory" subgroup (Figs. 1D-F ) demonstrated various degrees of corneal thinning, associated with focal stromal loss, an intact epithelium, and normal stromal reflectivity directly under the epithelium in the area of thinning. Epithelial marsupialization was evident on HR-OCT in two patients (patient 1, Fig. 1D, and patient 4, Fig. 1E ), and stromal cavity formation in one (patient 3, image not shown).
Five patients, however, had previous inflammatory symptoms and/or signs in the form of pain, photophobia, and injection, which historically had improved with either topical or systemic corticosteroids. None of these patients had a known history of an epithelial defect. Two of the 5 patients had a history of rheumatoid arthritis (patients 8 and 9), one a history of varicella zoster ophthalmicus affecting the right eye (patient 8), and 3 did not have a known systemic autoimmune or infectious disorder (Table 1) . At the time of HR-OCT imaging, 1 patient had active symptoms and signs of inflammation in the form of pain, tearing, and conjunctival injection (patient 6), whereas 4 patients were without symptoms/signs of inflammation. Two were using topical cyclosporine emulsion 0.05%, 1 topical corticosteroid, and 1 both agents at the time of HR-OCT imaging. Patients with a history of inflammation had a variety of clinical presentations including inferior (patients 7, 8, and 9), superior (patient 10), and diffuse (patient 6) thinning of various lengths and depths. One patient had associated bulbar Fig. 2A ) at the time of HR-OCT imaging. In all 5 patients, HR-OCT images were different when compared with those of the noninflammatory group. Noted were an intact epithelium, broad tissue loss, and change in the character of the underlying stroma. Specifically, there was a hyperreflective band of varying density in the stroma, directly below the epithelium in the area of thinning (white arrows, Figs. 2D-F).
DISCUSSION
Corneal thinning can have a multitude of potential etiologies, which may not be evident during the clinical examination. Inflammatory diseases such as rheumatoid arthritis and lupus are examples of conditions that have been associated with PUK, whereas diseases such as TMD are believed to occur without inflammation in most cases. It can be difficult for the physician to determine the cause of peripheral corneal thinning, especially if no active inflammation is observed and/or the disease course is unknown. The etiology of thinning is an important consideration, because therapy depends on the underlying cause of the condition. Additionally, if inflammation plays a key role in the pathophysiology of a disease process, prognosis and followup will vary compared with a degenerative condition.
HR-OCT provides a noninvasive, cross-sectional, highresolution image of the corneal structure. 18 It has been shown to be clinically useful for the examination, diagnosis, and management of various anterior segment pathologies. [11] [12] [13] [14] [15] For the study of diseases leading to thinning of the peripheral cornea, however, the utility of this imaging modality is not well studied. 19 Recently, Hattori et al 16 used HR-OCT to evaluate morphologic changes in TMD and demonstrated the existence of cavity formation in the peripheral cornea associated with the area of corneal thinning. The authors of this article hypothesized that progressive stromal abnormalities may induce cavity formation in the peripheral stroma while maintaining intact epithelial and endothelial layers. However, the authors did not elaborate on whether this pattern was exclusive to TMD or whether this could be seen in other peripheral pathologies. Others have used different imaging modalities such as confocal microscopy to image the corneas of patients with classic TMD 20,21 but did not describe any specific patterns of thinning. Importantly, no reports comment on how HR-OCT or other imaging modalities can help differentiate TMD from other peripheral corneal diseases that also lead to thinning. For example, a report of 14 eyes of 9 patients demonstrated the value of 3D HR-OCT in identifying topographic patterns in eyes with Mooren ulcers. 22 However, the authors did not comment on whether there were any distinctive descriptive features of Mooren ulcers on 3D HR-OCT images that could help differentiate this condition from others with similar physical findings.
In our study, patients with white, quiet eyes and thus presumed "classic" TMD showed an intact epithelium, focal stromal thinning, and the stroma under the epithelium was normal in character. Interestingly, 2 eyes had epithelial marsupialization and 1 eye had cavity formation on HR-OCT, consistent with reports in the literature. 7, 16 However, the significance of these patterns of thinning and whether they can point to a degenerative process when encountered are unclear. Perhaps marsupialization occurred as epithelium persisted around a longstanding corneal melting process.
In contrast, patients with a history of inflammation, regardless of its initial trigger, had a bright hyperreflective band on HR-OCT imaging directly under the epithelium in the area of thinning, but no groove pattern or cavity formation. Interestingly, this area of hyperreflectivity was seen in 4 eyes with no clinical signs of inflammation at the time of HR-OCT imaging. Although the clinical photograph for patient 9 shows bulbar hyperemia (Fig. 2C) , the HR-OCT was obtained 1 month later when the patient was not actively inflamed (Fig. 2F) . We suspect that this hyperreflective band may be a clue that previous inflammatory mediators or inflammatory cells were present in that area of the cornea, or it may be stromal scarring associated with previous episodes of inflammation. The hyperreflective band seems to be a nonspecific finding of inflammation as this finding has been described in patients after persistent epithelial defects, corneal ulcers, and phototherapeutic keratectomy. None of our patients, however, had a known history of a persistent epithelial defect or phototherapeutic keratectomy. A limitation of our study is that patients with frank PUK or Mooren ulcers were not included, and this is an important avenue of future study.
Our findings are encouraging because, ultimately, treatment is dictated by whether inflammation plays a role in the corneal thinning. Improved understanding of the etiology of thinning could better direct the evaluation and management of the patient. Despite these encouraging initial observations, ours is a preliminary study, and larger studies with longitudinal follow-up will be needed to validate our findings. In conclusion, we found a difference on HR-OCT imaging in patients with peripheral corneal thinning and signs/symptoms of inflammation when compared with patients in whom the thinning was clinically attributed to a noninflammatory degenerative process. As such, HR-OCT may be a useful tool in differentiating inflammatory versus degenerative peripheral corneal thinning.
